Matthew Link

Insider Reports History

Location
San Diego, CA
Signature
/s/ Jeremy Hayden, Attorney-in-Fact for Matthew Link
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Matthew Link:

Company Role Class Num Shares Value Price $ Report Date Ownership
Sight Sciences, Inc. Chief Commercial Officer Common Stock 832,293 $3,410,736 $4.10 02 Jul 2025 Direct
FibroBiologics, Inc. Director Stock Option (Right to Buy) 22,000 12 Jun 2025 Direct

Insider Reports Filed by Matthew Link

Symbol Company Period Transactions Value $ Form Type Role Filing Time
SGHT Sight Sciences, Inc. 31 Aug 2025 0 $0 4 Chief Commercial Officer 03 Sep 2025, 16:22
SGHT Sight Sciences, Inc. 02 Jul 2025 1 -$20,035 4 Chief Commercial Officer 07 Jul 2025, 21:24
FBLG FibroBiologics, Inc. 12 Jun 2025 1 $0 4 Director 12 Jun 2025, 19:26
SGHT Sight Sciences, Inc. 16 May 2025 1 +$20,012 4 Chief Commercial Officer 21 May 2025, 20:37
SGHT Sight Sciences, Inc. 02 Apr 2025 1 -$11,642 4 Chief Commercial Officer 03 Apr 2025, 21:56
SGHT Sight Sciences, Inc. 11 Mar 2025 1 $0 4 Chief Commercial Officer 13 Mar 2025, 21:52
SGHT Sight Sciences, Inc. 18 Oct 2024 2 -$244,901 4 Chief Commercial Officer 21 Oct 2024, 21:46
SGHT Sight Sciences, Inc. 16 Oct 2024 2 -$244,878 4 Chief Commercial Officer 18 Oct 2024, 19:43
FBLG FibroBiologics, Inc. 27 Aug 2024 1 $0 4 Director 27 Aug 2024, 19:54
FBLG FibroBiologics, Inc. 24 Jan 2024 0 $0 3/A Director 13 Aug 2024, 16:01
FBLG FibroBiologics Inc. 24 Jan 2024 0 $0 3 Director 13 Feb 2024, 18:28
SGHT Sight Sciences, Inc. 14 Nov 2023 2 $0 4 Chief Commercial Officer 16 Nov 2023, 18:49
SGHT Sight Sciences, Inc. 11 Sep 2023 0 $0 3 Chief Commercial Officer 12 Sep 2023, 06:16